Document |
Document Title |
WO/1995/014688A1 |
The application relates to derivatives of 2,3,5,6-tetrafluorobenzoic acid of formula (I) wherein Y represents oxygen or sulphur and X represents the groups -O- N=CR1R2, -OR3, -OCHR4-CO-NR5R6 or -NR7R8 as well as a process for manufacturi...
|
WO/1995/013262A1 |
Compounds of formula (I) are described wherein R1 is hydrogen, -(lower alkyl)q(CO2R6 or OH), -CN, -C(R7)=NOR8, NO2, -O(lower alkyl)R9, -CC-R10, -CR11=C(R12)(R13), -C(=O)CH2C(=O)CO2H, -CO(R14), alkylthio, alkylsulphinyl, alkylsulphonyl, c...
|
WO/1995/012572A1 |
The present invention provides a compound of formula (I) processes for the preparation of the compounds of the invention in addition to intermediates useful in these processes, a pharmaceutical composition, and a method of treating disor...
|
WO/1995/011226A1 |
A substituted benzene derivative of formula (I), wherein A is an aryloxy group which may be substituted, an arylthio group which may be substituted or -ON=C(R1)R2, each of R1 and R2 which are independent of each other is an alkyl group w...
|
WO/1995/011231A1 |
The current invention discloses useful pharmaceutical compositions containing amidino derivatives of formula (I) as nitric oxide synthase inhibitors.
|
WO/1995/011224A1 |
Intermediates and processes are disclosed which are useful for the preparation of a substantially pure compound of formula (3), wherein R6 and R7 are each hydrogen or R6 and R7 are independently selected from (i), wherein Ra and Rb are i...
|
WO/1995/007269A1 |
The invention relates to retroviral protease inhibitors of the general formula (I): W-(A)n-B-(A*)m-V where W, A, B, A*, V, n and m are as defined herein, including related prodrugs of general formula (I) comprising a solubilising group w...
|
WO/1995/007266A1 |
The invention concerns substituted lactic-acid derivatives, containing an organic nitrogen group in the beta position, of general formula (I) in which the substituents R2 to R5 and X are as defined in the description and N is one of the ...
|
WO/1995/007291A1 |
Kininogenase inhibiting peptides or peptide analogues with C-terminal residues related to agmatine or noragmatine.
|
WO/1995/006029A1 |
Described are improved phase-transfer catalyzed processes for the higher-yield enantioselective synthesis of precursors for alpha-alkyl amino acids. The alpha-alkylation of N-blocked amino acid esters is carried out with alkyl chlorides ...
|
WO/1995/004552A2 |
The invention concerns ligands, e.g. based on alkylene amine oxime particularly butylene amine oxime ring structures, and radiometal complexes thereof. The radiometal complexes are intrinsically capable of localising in tumours or hypoxi...
|
WO/1995/004027A1 |
Compounds of formula (I) and salts thereof are useful for treating accumulation of calcium in brain cells, wherein X represents O, S, NH or a bond; p and q independently represent 0-4 such that the sum of p + q is at least 1; R1 and R2 e...
|
WO/1995/002576A1 |
Process for the preparation of N-carbonylarylimines of general formula (I) by desulphonating a sulphone of general formula (II). The N-carbonylarylimines of general formula (I) are particularly useful for the preparation of therapeutical...
|
WO/1995/001957A1 |
An improved process for oximation of carbonyl compounds, such as ketones and aldehydes by oximation with hydroxylamine including oximation processes carried out in the presence of a catalytic amount of a phase transfer catalyst comprised...
|
WO/1995/001329A1 |
A process for producing an alpha-hydroxyiminophenylacetonitrile represented by general formula [II], (wherein R1, R2, R3 and Z are each as defined in the specification) by reacting a crude nitrile containing a phenylacetonitrile represen...
|
WO/1995/001330A1 |
A process for producing an alpha-alkoxyiminophenylacetonitrile represented by general formula [III], (wherein R1, R2, R3 and Y are each as defined in the specification) by reacting an alkali metal salt of an alpha-hydroxyiminophenylaceto...
|
WO/1995/001327A1 |
Thermotropic polyreas produced by the (poly)addition of at least one polyisocyanate with at least one thermotropic aromatic diamine including imine junctions and having general formula H2N - R1 - N = CH - R2 - CH = N - R3 - NH2 wherein e...
|
WO/1995/001328A1 |
A process for producing a carboxylic acid derivative represented by general formula [VIII], (wherein R1, R2, R3 and L are each as defined in the specification), which comprises reacting a benzyl halide with a cyano compound to give a phe...
|
WO/1994/027947A1 |
This invention relates to substituted phenylcyclopropane derivatives, which carry various substituents on the cyclopropane ring, to processes for their preparation, to pharmaceutical compositions containing them, and to methods for their...
|
WO/1994/026696A1 |
Novel compounds of formula (1), and isomeric and/or tautomeric forms thereof, wherein A is C1-C3 alkylene or C3 alkenylene, each optionally substituted with 1 to 4 C1-C3 alkyl substituents; X is oxygen or a single bond; and R1 to R9 are ...
|
WO/1994/026697A1 |
A compound of formula (I), (II) or (III), in which R1 and R2 are independently a C1-C10 alkyl, alkoxy C1-C10, C5-C10 cycloalkyl or C5-C10 aryl radical which also contain 1 to 3 non-adjacent nitrogen, oxygen or sulphur atoms as heteroatom...
|
WO/1994/022812A1 |
Described are compounds of the formula (I) in which Y is oxygen or an NR6 group; Z1 and Z2 are hydrogen, halogen, alkyl, alkenyl, alkinyl, alkoxy, alkenyloxy, haloalkyl, haloalkoxy, haloalkenyloxy, cyano or nitro; R1 is hydrogen, alkyl, ...
|
WO/1994/021599A1 |
A compound with a platelet aggregation inhibitor activity, represented by the following general formula (I), and pharmacologically acceptable salt and solvate thereof. Examples of the compound are as in (II).
|
WO/1994/019331A1 |
The invention concerns compounds of formula (I) in which the subscript and the substituents are defined as: n is 0 or 1 to 4; X is 0 or S; Y is a five-membered aromatic heterocycle ring; R1 is nitro, cyano, halogen, alkyl, haloalkyl, alk...
|
WO/1994/018174A1 |
The present invention pertains to new substituted tetrahydropyridazine carboxamides of general formula (I), in which R1 stands for hydrogen or alkyl, R2 stands for alkyl carbonyl or alkoxy carbonyl or R1 and R2 together with the nitrogen...
|
WO/1994/015901A1 |
Compounds, compositions, and methods for modulating processes mediated by Retinoid X Receptors using retinoid-like compounds which have activity selective for members of the subclass of Retinoid X Receptors (RXRs), in preference to membe...
|
WO/1994/015904A1 |
A tranexamic acid prodrug of general formula (II), is prepared by conversion of tranexamic acid in aqueous solution into a salt. An aromatic aldehyde of the formula Ar-CHO, lacking alpha-hydrogen atom is added to the solution and water i...
|
WO/1994/015902A1 |
Compounds, compositions, and methods for modulating processes mediated by Retinoid X Receptors using retinoid-like compounds which have activity selective for members of the subclass of Retinoid X Receptors (RXRs), in preference to membe...
|
WO/1994/014755A1 |
A novel anti-active-oxygen agent which inhibits the generation of active oxygen species, is highly safe, can be preparated at a rather low cost, and contains an amino acid derivative represented by general formula (I) or a salt thereof a...
|
WO/1994/014436A1 |
A retroviral protease inhibiting compound of formula (A) is disclosed.
|
WO/1994/014757A1 |
In order to prepare hydroxylamine-ethers having formula (I), in which X stands for NO2, CN, halogen, alkyl and halogen alkyl; Y stands for H, NO2, CN, halogen, alkyl and halogen alkyl; n equals 0 to 2 or 1 to 4 when Y and all X's stand f...
|
WO/1994/014742A1 |
Compounds of general formula (1) are described wherein Y is a halogen atom or a group -OR1, where R1 is an optionally substituted alkyl group; X is -O-, -S- or -N(R8)-, where R8 is a hydrogen atom or an alkyl group; R2 is an optionally s...
|
WO/1994/012277A1 |
The invention concerns new oxidation catalysts, methods of producing them and their use. These catalysts consist of titanium silicalites crystallized in situ on to activated charcoal or metal oxides. The titanium silicalite content lies ...
|
WO/1994/011340A1 |
A compound representd by general formula (I), a salt thereof, and a pest control agent, wherein: X represents halogen, alkyl, alkoxy, cycloalkyloxy, alkylsulfonyloxy, alkylthio or alkylsulfonyl; R1 represents hydrogen or alkyl; R2 repres...
|
WO/1994/011334A1 |
Compounds of general formula (I) in which the index and the constituents have the meanings below: n: 0, 1, 2, 3 or 4; X: CHOCH3, CHCH3 or NOCH3; Y: O or NH; R1: nitro, cyano, halogen, alkyl, alkyl halide, alkoxy, alkoxy halide, alkylthio...
|
WO/1994/010249A1 |
A process of preparing a quinacridone of formula (VII), wherein X is methyl, chloro or fluoro, and n is 0, 1 or 2, which comprises : (a) treating a dialkylsuccinate of formula (II), wherein R is alkyl of 1 to 3 carbons atoms, with at lea...
|
WO/1994/008948A2 |
A process for the preparation of a compound of formula (I), wherein Y is O, S(O)n (wherein n is 0, 1 or 2) or NR5; W is CH3O.CH=C.CO2CH3, CH3O.CH=C.CONR6R7, CH3O.N=C.CO2CH3 or CH3O.N=C.CONR6R7; R1 is hydrogen, C1-4 alkyl, C1-4 haloalkyl ...
|
WO/1994/008949A2 |
The invention concerns novel metal chelating compounds, and radiometal, e.g. technetium-99m complexes thereof. The compounds can be used to radiolabel small biologically active species with minimal effect on their biodistribution and act...
|
WO/1994/008968A1 |
A fungicidal compound having formula (I), wherein either: A is hydrogen, halogen, hydroxy, C1-4 alkyl, C1-4 alkoxy, C1-4 haloalkyl, C1-4 haloalkoxy, C1-4 alkylcarbonyl, C1-4 alkoxycarbonyl, phenoxy, nitro or cyano; and one of R1 and R2 i...
|
WO/1994/008943A1 |
A 2-amino-1,3-propanediol compound represented by general formula (I) or a pharmaceutically acceptable salt thereof, and an immunosuppressant containing the same as the active ingredient. In said formula R represents optionally substitut...
|
WO/1994/007847A1 |
Method of stereoselective preparation of a derivative of beta-phenylisoserine of formula (I) by the action of an N-carbonylbenzylimine of formula (II) on an optically active amide of a protected hydroxyacetic acid of formula (III), follo...
|
WO/1994/006280A1 |
Compositions and methods for treating a patient infected with a metazoan parasite by inhibiting the enzymatic action of the metazoan parasite protease. These compositions and methods have particular utility in the treatment of schistosom...
|
WO/1994/005153A1 |
Herbicidal compositions and method of use involving effective amounts of substituted benzene compounds to control the growth of undesired vegetation.
|
WO/1994/005626A1 |
An amide compound represented by general formula (I) (wherein R1 represents lower alkyl, etc.; n represents an integer of 0 to 3; R2 represents lower alkyl; R3 and R4 may be the same or different from each other and each represents hydro...
|
WO/1994/004489A1 |
Cyclohexenonoxime ethers have formula (I) in which the substituents have the following meaning: R1 stands for alkyl; R2 for alkyl, halogen alkyl, alkenyl, halogen alkenyl, alkinyl or halogen alkinyl; -A1-O-N=CH-Ph or A2-W, in which A1 st...
|
WO/1994/003557A1 |
The present invention relates to nonlinear optical materials comprising aminoaryl hydrazones and to nonlinear optical polymeric compositions containing recurring covalently bonded moieties derived from the aminoaryl hydrazones of the inv...
|
WO/1993/025588A1 |
The invention concerns dispersions or solutions of a polymerizate, polycondensate or polyadduct formed by a radical reaction and including 0.001 to 20 % by wt. of aldehyde-CHO or ketone-CO-groups, the dispersion or solution containing as...
|
WO/1993/025519A1 |
The invention concerns copolymerizable oxime ethers of generale formula (I), in which A is a bivalent link group; R?1¿ is a hydrogen atom or a C¿1? to C¿4? alkyl group; and R?2¿ and R?3¿, independently of each other, may be a hydrog...
|
WO/1993/023357A1 |
The present invention relates to stilbene derivatives which possess utility as anti-cancer agents. The compounds can be used to treat cancers which are susceptible to treatment therewith, and can be utilized in a method of treating such ...
|
WO/1993/022280A1 |
Substituted cyclohexene-1,2-bicarboxylic acid derivatives (I), (R?1¿, R?2¿ = H, possibly substituted C¿1?-C¿6? alkyl, C¿3?-C¿6? alkenyl or C¿3?-C¿6? alkinyl, C¿3?-C¿8? cycloalkyl, possibly substituted phenyl or heterocyclyl) an...
|